Claims for Patent: 5,462,535

✉ Email this page to a colleague

Summary for Patent: 5,462,535

Title:	Syringe system
Abstract:	An insulin injection system comprises a pen shaped syringe with a cartridge containing insulin, and an injection needle. The needle is a G30 needle and the insulin is a type which may freely flow through a G30 needle. When the insulin is the type comprising suspended crystals the maximal dimension of any crystal is 15 μm.
Inventor(s):	Frits F. Bonnichsen, Peter N. Jorgensen
Assignee:	Novo Nordisk AS
Application Number:	US08/323,401
Patent Claims:

Details for Patent 5,462,535

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	NOVOLIN R	insulin human	Injection	019938	June 25, 1991	5,462,535	2014-10-14
Novo Nordisk Inc.	NOVOLIN R	insulin human	Injection	019938	June 01, 2018	5,462,535	2014-10-14
Novo Nordisk Inc.	NOVOLIN 70/30	insulin isophane human and insulin human	Injection	019991	June 25, 1991	5,462,535	2014-10-14
Novo Nordisk Inc.	NOVOLIN 70/30	insulin isophane human and insulin human	Injection	019991	June 01, 2018	5,462,535	2014-10-14
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 5,462,535

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	9300948	⤷ Get Started Free
United States of America	5984906	⤷ Get Started Free
United States of America	5599323	⤷ Get Started Free
Japan	H1157006	⤷ Get Started Free
Japan	H0999079	⤷ Get Started Free
Japan	H06509004	⤷ Get Started Free
Japan	2918849	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.